You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 290 No. 10, September 10, 2003 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Letters
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Related articles
 •Similar articles in JAMA
 Topic Collections
 •Psychiatry
 •Depression
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati
What's this?

Neurochemical Aspects of Susceptibility to Depression

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

To the Editor: Dr Bremner and colleagues1 found that depletion of norepinephrine and dopamine with {alpha}-methylparatyrosine (AMPT) induced a return of depressive symptoms in 11 of 18 patients receiving desipramine. They also found that this was associated with significant decreases in brain metabolic activity in the dorsolateral prefrontal and orbitofrontal cortex and thalamus as measured by positron emission tomography (PET). The authors suggested that these findings of regional reductions in brain metabolic activity are similar to those of their previous study of tryptophan depletion, in which return of depressive symptoms in patients receiving serotonin reuptake inhibitors was associated with similar regional changes.2 These findings indicate that serotonergic and catecholaminergic systems may have common postsynaptic effects in brain regions involved in mediating depressive symptoms, perhaps through complex interactions among monoaminergic systems.

Using simultaneous tryptophan, tyrosine, and phenylalanine depletion (combined monoamine precursor depletion), my colleagues and I found that reductions in both . . . [Full Text of this Article]

Pradeep J. Nathan, PhD, MRACI, CChem, FCP
Brain Sciences Institute
Swinburne University
Victoria, Australia



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati     What's this?

RELATED ARTICLES

Neurochemical Aspects of Susceptibility to Depression—Reply
J. Douglas Bremner
JAMA. 2003;290(10):1316.
EXTRACT | FULL TEXT  

Regional Brain Metabolic Correlates of {alpha}-Methylparatyrosine–Induced Depressive Symptoms: Implications for the Neural Circuitry of Depression
J. Douglas Bremner, Meena Vythilingam, Chin K. Ng, Eric Vermetten, Ahsan Nazeer, Dan A. Oren, Robert M. Berman, and Dennis S. Charney
JAMA. 2003;289(23):3125-3134.
ABSTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Visceral Fat in Hypertension: Influence on Insulin Resistance and {beta}-Cell Function
Sironi et al.
Hypertension 2004;44:127-133.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2003 American Medical Association. All Rights Reserved.